Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,454 | -8,797 | -6,640 | -4,588 | -2,357 |
| Depreciation Amortization | 112 | 497 | 384 | 266 | 140 |
| Other Working Capital | 284 | 178 | 163 | 252 | 68 |
| Other Operating Activity | 1,169 | 1,537 | 1,202 | 870 | 446 |
| Operating Cash Flow | $-1,889 | $-6,585 | $-4,891 | $-3,200 | $-1,703 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -93 | -98 | -37 | -29 | -15 |
| Other Investing Activity | 122 | -2,000 | 0 | 0 | 0 |
| Investing Cash Flow | $29 | $-2,098 | $-37 | $-29 | $-15 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1 | -2 | -2 | -1 | -1 |
| Common Stock Issued | 4,975 | 7,927 | 5,022 | 4,871 | N/A |
| Other Financing Activity | 71 | -71 | 0 | 0 | 0 |
| Financing Cash Flow | $5,045 | $7,854 | $5,020 | $4,870 | $-1 |
| Beginning Cash Position | 4,678 | 5,506 | 5,506 | 5,506 | 5,506 |
| End Cash Position | 7,863 | 4,678 | 5,598 | 7,146 | 3,788 |
| Net Cash Flow | $3,185 | $-828 | $92 | $1,640 | $-1,718 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,889 | -6,585 | -4,891 | -3,200 | -1,703 |
| Capital Expenditure | -93 | -98 | -37 | -29 | -15 |
| Free Cash Flow | -1,982 | -6,683 | -4,928 | -3,229 | -1,718 |